FdaApplication
ANDA 208921
Identifiers
- fda_app_no: ANDA208921
Properties
| Property | Value |
|---|---|
| applicant_name | YILING PHARMACEUTICAL LTD |
| application_type | ANDA |
| approval_date | 2018-06-22 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CIPROFLOXACIN HYDROCHLORIDE | CIPROFLOXACIN HYDROCHLORIDE | EQ 250MG BASE | TABLET;ORAL |
| CIPROFLOXACIN HYDROCHLORIDE | CIPROFLOXACIN HYDROCHLORIDE | EQ 500MG BASE | TABLET;ORAL |
2 products